REFILE-BRIEF-Astex Pharmaceuticals responds to further misleading claims made by Sarissa Capital
Oct 9 (Reuters) - Astex Pharmaceuticals Inc : * Says disappointed that Sarissa Capital continues to mislead Astex
stockholders with information that is incomplete * Says $8.50 per share all-cash transaction with Otsuka was in the best
interests of all Astex stockholders * Says no third parties have approached Astex with an interest to acquire the
company * Source text for Eikon * Further company coverage
- Putin dissolves state news agency, tightens grip on Russia media
- North Korea says Kim's powerful uncle dismissed for 'criminal acts'
- Thai PM calls snap election, protesters want power now |
- Cold, ice grip U.S. as more snow to blanket East
- Protesters fell Lenin statue, tell Ukraine's president 'you're next'